Streamline Health Solutions (NASDAQ:STRM) Earns Sell Rating from Analysts at StockNews.com

Equities research analysts at StockNews.com began coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research report issued to clients and investors on Thursday. The brokerage set a “sell” rating on the stock.

Streamline Health Solutions Stock Performance

NASDAQ:STRM opened at $0.46 on Thursday. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.62. The company has a market capitalization of $28.58 million, a P/E ratio of -1.44 and a beta of 1.58. The firm has a 50-day moving average price of $0.39 and a two-hundred day moving average price of $0.43. Streamline Health Solutions has a twelve month low of $0.21 and a twelve month high of $1.44.

Streamline Health Solutions (NASDAQ:STRM) last released its quarterly earnings results on Monday, April 29th. The company reported ($0.02) EPS for the quarter. Streamline Health Solutions had a negative net margin of 85.83% and a negative return on equity of 35.69%. The business had revenue of $5.36 million during the quarter.

Institutional Trading of Streamline Health Solutions

Institutional investors and hedge funds have recently made changes to their positions in the stock. Nicholas Hoffman & Company LLC. increased its position in Streamline Health Solutions by 10.9% during the 4th quarter. Nicholas Hoffman & Company LLC. now owns 740,983 shares of the company’s stock worth $315,000 after purchasing an additional 72,993 shares in the last quarter. Perkins Capital Management Inc. boosted its stake in shares of Streamline Health Solutions by 33.7% during the 4th quarter. Perkins Capital Management Inc. now owns 1,999,405 shares of the company’s stock worth $850,000 after purchasing an additional 504,000 shares during the last quarter. Austin Wealth Management LLC grew its holdings in shares of Streamline Health Solutions by 100.2% during the fourth quarter. Austin Wealth Management LLC now owns 935,519 shares of the company’s stock worth $402,000 after buying an additional 468,242 shares in the last quarter. Cerity Partners LLC purchased a new position in shares of Streamline Health Solutions during the fourth quarter valued at approximately $128,000. Finally, Mesirow Financial Investment Management Inc. purchased a new position in shares of Streamline Health Solutions during the first quarter valued at approximately $59,000. 31.74% of the stock is currently owned by hedge funds and other institutional investors.

Streamline Health Solutions Company Profile

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.